VC Fund Dossiers

360 Capital is one of Europe's most successful old-school VC shops that actually delivers results—their Preligens exit to Safran for €220M in 2024 and backing Exotec to become France's first industrial unicorn proves they know how to pick winners and get liquidity. Founded in 1997, they've survived multiple cycles and have the conviction to back deep tech when others chase software. Fausto Boni is a genuine operator with McKinsey pedigree who sits on boards and gets his hands dirty. The dual Paris-Milan setup gives them unique access to Southern European talent that coastal VCs miss. Their 71% seed to Series A conversion rate (92% including exits) is exceptional. Watch for their climate tech focus with the new €140M 360 LIFE II fund—they're betting big on energy transition when others just talk about it.

Act met Barry Napier "over a decade ago" and made "the largest seed investment we possibly could" - this is a fund that bets big early and doubles down on winners. They explicitly say "We have never been the loudest venture firm" and "don't want to add to the noise of VCs making it about them." Strong exit track record including SilverCloud Health (acquired by Amwell), Decawave (acquired by Qorvo), and 34 total portfolio exits. Their strategy is clear: "find the best company builders at the earliest stages and continue to back them again and again." This isn't a spray-and-pray fund - they're conviction-driven, founder-focused, and have the dry powder (€140M Fund VI) to support you through multiple rounds.

Aglae is essentially Bernard Arnault's tech investment arm masquerading as a standalone VC - which is both their superpower and their Achilles heel. They have stupid money (LVMH backing means they can write big checks without blinking), phenomenal brand access through the luxury ecosystem, and a track record that includes some absolute bangers. But here's the catch: they're not really building a venture brand, they're executing family office investment strategy. The team is solid but small, and while Antoine brings decent deal flow, this isn't Sequoia-level pattern recognition. If you need growth capital and can benefit from luxury/premium brand connections, they're golden. If you want hands-on operational support or deep sector expertise, look elsewhere.

Alliance is the rare Nordic VC that actually walks the walk on 'founder-friendly' instead of just talking about it. From your very first meeting, you're speaking directly with a partner — no junior associates wasting your time. Every partner has equal voting power and they make decisions by majority, but they value passionate conviction when a partner pounds the table for a deal. The sustainability angle isn't just marketing fluff — they genuinely believe it drives long-term value creation. Their exit rate is 19 percentage points higher than average VCs, which suggests they know how to pick and support winners. With offices across the Nordics and strong ties to Silicon Valley, they're well-positioned to help ambitious founders scale globally.

Armilar is the real deal - they've backed three unicorns (OutSystems, Feedzai, Sword Health) and have genuine deep-tech credibility spanning 25+ years. Their track record of generating returns is grounded on backing founders throughout their journey, not just writing checks. However, they work on 16 percentage points less than the average amount of lead investments, meaning they're selective but might not always lead your round. The fact they successfully raised €120M in 2025's brutal fundraising environment speaks volumes about LP confidence in their returns. The senior team has been working together for a decade with 60+ years of cumulative VC experience - this isn't a new fund with untested dynamics.

Axon is that rare breed - a publicly traded VC (BME: APG) with €685 million AUM that actually knows what they're doing. With 1 unicorn (Forto), 7 IPOs, and 11 acquisitions in their portfolio, they've got the track record to back up the hype. The dual consulting-investment model is either genius or a distraction - it gives them deep sector insights but might split focus. Francisco Velazquez landing on the EU Innovation Council board shows they have serious Brussels connections, which matters for regulatory-heavy sectors. They're heavy on Spain/Southern Europe but expanding globally, so perfect if you're a Spanish startup needing local expertise and international ambitions. The climate tech push feels authentic given their track record, not just trend-chasing.

Bayern Kapital operates as a co-investor alongside private investors, adhering to the pari-passu principle, and typically holds minority stakes. We invest according to the pari-passu principle. In the case of a financing round, this means that all parties involved are treated equally and must invest the same amount of capital as Bayern Kapital. This is both their strength and potential limitation - they're patient, government-backed capital that won't push for quick exits, but they require private lead investors to move. With 3 unicorns (IQM, Quantum Systems, EGYM) and strong exits like MorphoSys, they clearly pick winners, but their bureaucratic structure means slower decisions than pure private funds. Their 8-10 year investment horizons and €700M+ AUM make them ideal for deep tech that needs patient capital, but expect more process and committees than your typical VC.

Big Pi is the real deal in the Greek/diaspora space - they're not just tourist money but serious operators with legit exits under their belt (Accusonus to Meta for €70-100M). The team brings actual entrepreneurial chops: Marco built Upstream to €230M revenue, Nick was at Prime Ventures doing serious European deals, and Alex literally helped create the Python data science stack. They require portfolio companies to maintain substantial Greek operations, which is both a feature (cheap talent, government support) and potential bug (geographic constraint). Their "tech-first" mandate with IP requirements means they actually understand what defensible tech looks like, unlike funds that chase flashy B2C plays.

Bright Pixel is basically Sonae's corporate venture arm with €250M deployed across 60+ companies, which sounds impressive until you realize they're essentially a retail conglomerate trying to stay relevant in tech. The good news: they have four unicorns including Feedzai and Arctic Wolf, proving they can spot winners. The reality check: as a corporate VC, they're always going to prioritize strategic value over pure financial returns, which means potential acqui-hire pressure down the road. Their team seems genuinely knowledgeable about cybersecurity and retail tech, but founders should expect longer decision cycles and more stakeholder management than with pure-play VCs.

This is Spain's establishment VC - they're the corporate venture arm of CriteriaCaixa, which manages over €25 billion and is backed by la Caixa Foundation. They've been around since 2007 and have made 300+ investments, so they know what they're doing, but they're also exactly what you'd expect from a big Spanish bank's VC arm. The good news: they have serious capital staying power, they actually stick around for follow-on rounds, and they exit 20% more often than average. The reality check: they're not exactly known for being the fastest movers or most founder-friendly when it comes to terms. New CEO Jordi Ros comes from 20 years of traditional corporate finance, not startup-land.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.